Guangzhou LBP Medicine Science & Technology Co Ltd (688393) — Tangible Net Worth Ratio
Guangzhou LBP Medicine Science & Technology Co Ltd (688393) has a Tangible Net Worth Ratio of 96.7% as of September 2025. This metric is calculated by deducting intangible assets (CN¥39.63 Million) from net assets (CN¥1.20 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Guangzhou LBP Medicine Science & Technol equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Guangzhou LBP Medicine Science & Technology Co Ltd Tangible Net Worth Ratio (2011–2024)
This chart shows how Guangzhou LBP Medicine Science & Technology Co Ltd's Tangible Net Worth Ratio has changed across 12 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 96.7%, reflecting net assets of CN¥1.20 Billion with intangible assets of CN¥39.63 Million CNY. For live market cap and overall valuation, see Guangzhou LBP Medicine Science & Technol stock valuation.
Annual Tangible Net Worth Ratio for Guangzhou LBP Medicine Science & Technology Co Ltd (2011–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Guangzhou LBP Medicine Science & Technology Co Ltd from 2011 to 2024, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Guangzhou LBP Medicine Science & Technol capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.3% | CN¥1.23 Billion | CN¥32.65 Million | CN¥1.36 Billion | ▼ -0.8 pp |
| 2023 | 98.2% | CN¥1.24 Billion | CN¥22.64 Million | CN¥1.40 Billion | ▼ -1.2 pp |
| 2022 | 99.4% | CN¥1.22 Billion | CN¥7.25 Million | CN¥1.39 Billion | ▼ -0.1 pp |
| 2021 | 99.5% | CN¥1.21 Billion | CN¥5.85 Million | CN¥1.37 Billion | ▲ +0.0 pp |
| 2020 | 99.5% | CN¥1.17 Billion | CN¥5.77 Million | CN¥1.29 Billion | ▲ +0.8 pp |
| 2019 | 98.7% | CN¥444.63 Million | CN¥5.92 Million | CN¥537.96 Million | ▲ +0.2 pp |
| 2018 | 98.4% | CN¥389.32 Million | CN¥6.06 Million | CN¥476.56 Million | ▲ +0.3 pp |
| 2017 | 98.1% | CN¥346.28 Million | CN¥6.59 Million | CN¥412.06 Million | ▲ +0.2 pp |
| 2016 | 97.9% | CN¥320.94 Million | CN¥6.88 Million | CN¥357.02 Million | ▼ -2.0 pp |
| 2013 | 99.9% | CN¥215.00 Million | CN¥226.50K | CN¥257.13 Million | ▲ +0.0 pp |
| 2012 | 99.9% | CN¥173.32 Million | CN¥228.20K | CN¥191.92 Million | ▲ +0.1 pp |
| 2011 | 99.8% | CN¥48.09 Million | CN¥114.30K | CN¥111.40 Million | — |